Intelligent Bio Solutions ( (INBS) ) has provided an update.
On February 7, 2025, Intelligent Bio Solutions announced that Avon Freight Group has adopted its non-invasive Intelligent Fingerprinting Drug Testing Solution for random drug testing at its UK sites. This move by Avon, a significant logistics firm, highlights a shift towards more respectful and efficient drug testing methods, boosting workplace safety and culture. This partnership expands INBS’s network to over 400 accounts in 19 countries, reinforcing its industry leadership as the UK drug testing market is projected to reach $453 million by 2030. The company’s strategic growth, including a planned U.S. expansion following an FDA submission, positions it to address growing demand for scalable and cost-effective drug testing solutions.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. (INBS) is a medical technology company specializing in rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System. This system utilizes fingerprint sweat analysis to detect drugs like opiates, cocaine, methamphetamine, and cannabis within minutes, offering a hygienic and cost-effective alternative for safety-critical industries such as construction, manufacturing, transport, and logistics.
YTD Price Performance: 38.30%
Average Trading Volume: 145,222
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $9.37M
For an in-depth examination of INBS stock, go to TipRanks’ Stock Analysis page.